O-I Glass, Inc. /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that O-I Glass, Inc. /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.43B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.53B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $7.11B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $6.86B | Feb 12, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.50B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.21B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $972.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $1.21B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $1.28B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.33B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.31B | Feb 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($129.00M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($106.00M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | ($103.00M) | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $584.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $149.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $249.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | ($400.00M) | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $257.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $180.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $209.00M | Feb 14, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $38.00M | Feb 12, 2025 |
| FY2024 | Dec 31, 2023 | $67.00M | Feb 12, 2025 |
| FY2024 | Dec 31, 2022 | $805.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $332.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $353.00M | Feb 8, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $80.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $92.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $79.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $82.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $75.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $68.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $70.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $60.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $65.00M | Feb 14, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $434.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $445.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $540.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $496.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $433.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $403.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $439.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $483.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $484.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $503.00M | Feb 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $600.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $489.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $818.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $154.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $687.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $457.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $405.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $791.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $721.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $751.00M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $432.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $617.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $688.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $539.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $398.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $311.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $426.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $536.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $441.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $454.00M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.24B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $8.65B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $9.67B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $9.06B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $8.83B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $8.88B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $9.61B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $9.70B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $9.76B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $9.14B | Feb 14, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.08B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.61B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.42B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $720.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $297.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $467.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $786.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $808.00M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $254.00M | Feb 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.47B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $1.81B | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $1.84B | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $1.95B | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $1.93B | Feb 8, 2023 |
| FY2021 | Dec 31, 2018 | $2.51B | Feb 9, 2022 |
| FY2020 | Dec 31, 2017 | $2.59B | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | $2.46B | Feb 21, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $548.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $676.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $782.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $885.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $301.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $152.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | ($89.00M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $333.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $84.00M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | ($96.00M) | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $759.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $734.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $913.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $773.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $725.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $563.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $551.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $512.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $492.00M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $492.00M | Feb 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $3.70B | Feb 9, 2012 |
| FY2010 | Dec 31, 2010 | $4.02B | Feb 10, 2011 |
| FY2010 | Dec 31, 2009 | $3.31B | Feb 10, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | (2) | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 14, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | (2) | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 14, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2009 | Dec 31, 2009 | 179.92M | Feb 10, 2010 |
| FY2009 | Dec 31, 2008 | 178.71M | Feb 10, 2010 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2020 | $8.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $31.00M | Feb 9, 2022 |